The Vertex Pharmaceuticals Incorporated (VRTX) gross profit margin is 86.1%, compared to the industry median of 64.9% and the 5-year historical average of 87.6%.
The Vertex Pharmaceuticals Incorporated (VRTX) operating income margin is 2.4%, compared to the industry median of (879.7%)) and the 5-year historical average of 38.9%.
The Vertex Pharmaceuticals Incorporated (VRTX) Free Cash Flow margin is (11.0%), compared to the industry median of (720.0%) and the 5-year historical average of 34.4%.
The Vertex Pharmaceuticals Incorporated (VRTX) earnings quality is 242.6%, compared to the industry median of 83.4% and the 5-year historical average of 125.6%.